Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q3 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.